Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Figlerowicz

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Nucleic Acids Research|July 9, 2005
A universal BMV-based RNA recombination system--how to search for general rules in RNA recombinationMagdalena Alejska, Magdalena Figlerowicz, Nelli Malinowska, et al.
Przeglad Epidemiologiczny|September 30, 2005
[Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C]Arleta Kowala-Piaskowska, Magdalena Figlerowicz, Iwona Mozer-Lisewska, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 10, 2005
Factors influencing early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirinArleta Kowala-Piaskowska, Wojciech Słuzewski, Magdalena Figlerowicz, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2007
Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis CArleta Kowala-Piaskowska, Iwona Mozer-Lisewska, Magdalena Figlerowicz, et al.
Vaccines|May 25, 2024
Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk-Follow Up StudyDagny Lorent, Rafał Nowak, Magdalena Figlerowicz, et al.
Clinical and Experimental Hepatology|September 1, 2017
Successful outcome of therapy of acute hepatitis C following sexual and parenteral exposure - report of two casesKatarzyna Mazur-Melewska, Anna Mania, Pawel Kemnitz, et al.
Journal of Child Neurology|June 20, 2022
Inflammatory Markers Combined With Metalloproteinase-9, Neopterin, and S100B Concentrations May Indicate the Pathogenesis of Central Nervous System Diseases in ChildrenKarol Lubarski, Anna Mania, Paweł Małecki, et al.
Postepy Dermatologii I Alergologii|July 11, 2015
Cat-scratch disease: a wide spectrum of clinical picturesKatarzyna Mazur-Melewska, Anna Mania, Paweł Kemnitz, et al.
Inflammation|October 26, 2005
Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirinArleta Kowala-Piaskowska, Iwona Mozer-Lisewska, Magdalena Figlerowicz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 9, 2013
Phylogeny and molecular evolution of the hepatitis C virusPaulina Jackowiak, Karolina Kuls, Lucyna Budzko, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Nucleic Acids Research|July 9, 2005
A universal BMV-based RNA recombination system--how to search for general rules in RNA recombinationMagdalena Alejska, Magdalena Figlerowicz, Nelli Malinowska, et al.
Przeglad Epidemiologiczny|September 30, 2005
[Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C]Arleta Kowala-Piaskowska, Magdalena Figlerowicz, Iwona Mozer-Lisewska, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 10, 2005
Factors influencing early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirinArleta Kowala-Piaskowska, Wojciech Słuzewski, Magdalena Figlerowicz, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2007
Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis CArleta Kowala-Piaskowska, Iwona Mozer-Lisewska, Magdalena Figlerowicz, et al.
Vaccines|May 25, 2024
Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk-Follow Up StudyDagny Lorent, Rafał Nowak, Magdalena Figlerowicz, et al.
Clinical and Experimental Hepatology|September 1, 2017
Successful outcome of therapy of acute hepatitis C following sexual and parenteral exposure - report of two casesKatarzyna Mazur-Melewska, Anna Mania, Pawel Kemnitz, et al.
Journal of Child Neurology|June 20, 2022
Inflammatory Markers Combined With Metalloproteinase-9, Neopterin, and S100B Concentrations May Indicate the Pathogenesis of Central Nervous System Diseases in ChildrenKarol Lubarski, Anna Mania, Paweł Małecki, et al.
Postepy Dermatologii I Alergologii|July 11, 2015
Cat-scratch disease: a wide spectrum of clinical picturesKatarzyna Mazur-Melewska, Anna Mania, Paweł Kemnitz, et al.
Inflammation|October 26, 2005
Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirinArleta Kowala-Piaskowska, Iwona Mozer-Lisewska, Magdalena Figlerowicz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 9, 2013
Phylogeny and molecular evolution of the hepatitis C virusPaulina Jackowiak, Karolina Kuls, Lucyna Budzko, et al.
Pageof 8